According to Biolife Solutions 's latest financial reports and stock price the company's current number of shares outstanding is 43,570,438. At the end of 2023 the company had 43,570,438 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 43.57 M | 1.82% |
2022 | 42.79 M | 2.68% |
2021 | 41.67 M | 26.44% |
2020 | 32.96 M | 59.9% |
2019 | 20.61 M | 11.94% |
2018 | 18.41 M | 33.99% |
2017 | 13.74 M | 7.39% |
2016 | 12.79 M | 4.01% |
2015 | 12.3 M | 1.88% |
2014 | 12.07 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Celanese CE | 109,000,000 | 150.17% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | 21,088,000 | -51.60% | ๐บ๐ธ USA |
Amyris AMRS | 365,603,738 | 739.11% | ๐บ๐ธ USA |